Related Experiment Videos
Glucocorticoids increase C/EBPbeta activity in the lung epithelium via phosphorylation
Tove Berg1, Lukas Didon, Jenny Barton
1Department of Medicine, Division for Respiratory Medicine, Karolinska Institute, Lung Research Laboratory, Karolinska University Hospital, Solna, Sweden.
Abstract:
Glucocorticoids are widely prescribed anti-inflammatory drugs used for the treatment of many inflammatory lung disorders. However, much still remains unknown about their molecular mechanisms of action. We have previously shown that glucocorticoid-induced transcription in the lung epithelial cell line NCI-H441 is mediated via C/EBP sites in the promoters of target genes, and is likely to involve the transcription factors C/EBPbeta and C/EBPdelta. Here, we report that C/EBPbeta is the most active C/EBP-factor in both human and mouse lung epithelium and that glucocorticoids induce DNA binding of C/EBPbeta in cultured primary mouse lung epithelial cells. Mechanistic studies in H441 cells revealed that glucocorticoids, acting via the glucocorticoid receptor, increase C/EBPbeta binding starting 10 min after stimulation. The mechanism is independent of de novo protein synthesis and involves phosphorylation of C/EBPbeta at Thr(235). Together this shows that glucocorticoids increase DNA-binding activity of C/EBPbeta via post-translational mechanism(s) involving phosphorylation.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Cell Specific Gene Expression
GPCRs Regulate Adenylyl Cylase Activity
Two...
Cushing Syndrome II: Pathophysiology
TGF - β Signaling Pathway
GPCR Desensitization